Kamada - Stock Price History | KMDA

Historical daily share price chart and data for Kamada since 2021 adjusted for splits. The latest closing stock price for Kamada as of September 27, 2021 is 5.40.
  • The all-time high Kamada stock closing price was 17.50 on March 05, 2014.
  • The Kamada 52-week high stock price is 8.85, which is 63.9% above the current share price.
  • The Kamada 52-week low stock price is 5.17, which is 4.3% below the current share price.
  • The average Kamada stock price for the last 52 weeks is 6.31.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Kamada Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 7.4541 7.0000 11.7300 4.5600 6.4800 -5.12%
2019 5.7374 5.1200 7.7000 4.9700 6.8300 36.60%
2018 5.2895 4.8000 6.3000 4.4000 5.0000 5.26%
2017 5.8270 5.8500 8.2500 4.2500 4.7500 -12.84%
2016 4.3905 4.2200 6.0000 3.4470 5.4500 31.45%
2015 4.0759 3.9700 4.9854 3.2350 4.1460 9.11%
2014 9.2078 15.2000 17.5000 3.0700 3.8000 -74.45%
2013 13.5768 10.1000 16.5900 9.8200 14.8700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.240B $0.133B
Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona, Israel.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29